Innospec's short interest has increased by 6.15%, with 334,000 shares sold short, representing 1.9% of available trading shares. The short interest is below its peer group average of 5.42%, suggesting a relatively moderate bearish sentiment.
Innospec Inc. (IOSP)
Common Stock · Currency in USD · XNAS
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
Company Info
SIC2800
Composite FIGIBBG000BMFNP4
CIK0001054905
IPOMay 13, 1998
Sectorchemicals & allied products
Highlights
Market Cap$1.84B
EPS$2.08
P/E Ratio35.59
Revenue$1.76B
Gross Profit$466.80M
Net Income$51.60M
Employees2,450
WSO24,890,467
Phone(720) 355-6451
Websitehttps://www.innospec.com
Related Tickers
SCL
Stepan Co.
$49.97 0.00%
FUL
H.B. Fuller Company
$60.51 0.00%
MTX
Minerals Technologies Inc
$69.30 0.00%
AVNT
Avient Corporation
$35.07 0.00%
CBT
Cabot Corporation
$75.93 0.00%
FNB
F.N.B. Corp
$16.86 0.00%
UBSI
United Bankshares Inc
$41.87 0.00%
IBOC
International Bancshares Corp
$67.77 0.00%
FFBC
First Financial Bancorp
$28.08 0.00%
FRME
First Merchants Corp
$39.43 0.00%
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Innospec Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Innospec Inc. (IOSP) has returned -3.79% so far this year and -11.29% over the past 12 months. Looking at the last ten years, IOSP has achieved an annualized return of 5.42%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
IOSP
1M-3.31%
6M-6.52%
YTD-3.79%
1Y-11.29%
5Y-6.45%
10Y5.42%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Innospec Inc. (IOSP) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.54% | -5.89% | -3.87% | 0.78% | ||||||||
| 2025 | 2.35% | -6.85% | -8.35% | -6.50% | -4.81% | -1.50% | -4.52% | 11.30% | -11.28% | -4.60% | 1.63% | 3.14% |
| 2024 | -5.19% | 6.27% | 3.25% | -6.99% | 8.55% | -5.92% | 6.28% | -12.18% | -1.63% | -4.70% | 9.35% | -7.05% |
| 2023 | 9.64% | -2.70% | -6.16% | -1.38% | -8.87% | 8.36% | 7.08% | 0.56% | -5.68% | -3.66% | 6.79% | 17.09% |
| 2022 | 2.27% | 2.91% | -2.50% | 2.33% | 6.24% | -6.86% | 7.04% | -7.66% | -7.43% | 15.68% | 9.97% | -7.59% |
| 2021 | -3.82% | 14.17% | 0.24% | -5.52% | 2.66% | -11.23% | -3.02% | 5.86% | -10.26% | 6.86% | -10.68% | 8.97% |
| 2020 | -3.24% | -14.71% | -20.20% | 8.94% | 8.76% | -0.53% | -3.18% | -1.23% | -14.85% | 4.16% | 23.17% | 8.65% |
| 2019 | 16.07% | 16.25% | 1.17% | 0.96% | -4.95% | 13.02% | 2.84% | -10.99% | 8.00% | 1.94% | 7.19% | 4.90% |
| 2018 | 1.27% | -9.10% | 5.70% | 5.98% | 5.87% | -0.84% | 6.30% | -3.84% | -0.78% | -13.15% | 9.60% | -17.57% |
| 2017 | 3.11% | -9.31% | -2.34% | 1.85% | -3.40% | 2.10% | -5.24% | -11.48% | 11.08% | 0.32% | 14.42% | -1.26% |
| 2016 | 12.54% | 0.12% | -4.72% | 9.26% | 18.16% | 2.60% | -1.15% | 8.68% | 3.63% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Innospec Inc. (IOSP) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of IOSP compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Innospec Inc. volatility is 1.78%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 1.83B | 1.73B | 1.71B | 1.60B | 1.57B | 1.40B | 1.47B | 1.47B | 1.41B | 1.18B | 1.03B | 999.90M | 794.70M | 579.40M | 568.80M |
| Equity Attributable To Parent (USD) | 1.33B | 1.21B | 1.15B | 1.04B | 1.03B | 944.40M | 918.50M | 825.00M | 793.90M | 653.50M | 605.00M | 515.90M | 409.40M | 317.00M | 343.10M |
| Equity Attributable To Noncontrolling Interest (USD) | 6.80M | 4.90M | 2.50M | 2.40M | 600.00K | 500.00K | 400.00K | 500.00K | 400.00K | 300.00K | 300.00K | - | - | - | - |
| Equity (USD) | 1.33B | 1.22B | 1.15B | 1.04B | 1.03B | 944.90M | 918.90M | 825.50M | 794.30M | 653.80M | 605.30M | 515.90M | 409.40M | 317.00M | 343.10M |
| Commitments and Contingencies (USD) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Non-current Liabilities (USD) | - | - | - | - | - | - | 187.80M | 143.70M | 135.90M | 75.70M | 85.60M | 121.70M | 81.70M | 85.10M | - |
| Long-term Debt (USD) | - | - | - | - | - | - | 58.60M | 207.60M | 218.40M | 268.80M | 133.00M | 139.40M | 148.00M | 30.00M | - |
| Noncurrent Liabilities (USD) | 139.40M | 147.20M | 186.30M | 157.50M | 201.30M | 200.10M | 246.40M | 351.30M | 354.30M | 344.50M | 218.60M | 261.10M | 229.70M | 115.10M | 79.70M |
| Other Current Liabilities (USD) | 185.40M | 207.60M | 207.90M | 240.50M | 187.90M | 153.70M | 181.50M | 169.80M | 143.70M | 123.50M | 153.90M | 135.30M | 92.30M | 90.00M | 92.70M |
| Accounts Payable (USD) | 174.70M | 163.80M | 163.60M | 165.30M | 148.70M | 98.70M | 122.00M | 126.80M | 117.90M | 59.60M | 52.20M | 87.60M | 63.30M | 57.30M | 53.30M |
| Current Liabilities (USD) | 360.10M | 371.40M | 371.50M | 405.80M | 336.60M | 252.40M | 303.50M | 296.60M | 261.60M | 183.10M | 206.10M | 222.90M | 155.60M | 147.30M | 146.00M |
| Liabilities (USD) | 499.50M | 518.60M | 557.80M | 563.30M | 537.90M | 452.50M | 549.90M | 647.90M | 615.90M | 527.60M | 424.70M | 484.00M | 385.30M | 262.40M | 225.70M |
| Other Non-current Assets (USD) | 474.00M | 443.00M | 496.10M | 465.20M | 570.90M | 545.10M | 526.30M | 476.80M | 489.40M | 438.50M | 326.60M | 323.80M | 200.10M | 164.40M | 184.90M |
| Intangible Assets (USD) | 67.70M | 65.40M | 57.30M | 45.00M | 57.50M | 75.30M | 113.50M | 136.30M | 163.30M | 144.40M | 168.70M | 181.10M | 126.80M | 68.60M | 17.70M |
| Fixed Assets (USD) | 286.10M | 269.70M | 268.30M | 220.90M | 214.40M | 210.80M | 198.70M | 196.40M | 196.00M | 157.40M | 76.00M | 80.80M | 60.40M | 49.80M | 45.90M |
| Noncurrent Assets (USD) | 827.80M | 778.10M | 821.70M | 731.10M | 842.80M | 831.20M | 838.50M | 809.50M | 848.70M | 740.30M | 571.30M | 585.70M | 387.30M | 282.80M | 248.50M |
| Other Current Assets (USD) | 333.00M | 313.90M | 225.80M | 164.90M | 166.00M | 124.80M | 93.70M | 136.20M | 107.20M | 112.90M | 155.30M | 56.70M | 106.90M | 38.50M | 81.00M |
| Prepaid Expenses (USD) | - | - | - | - | - | - | - | - | - | - | 6.10M | 8.30M | 5.80M | 4.10M | 4.00M |
| Inventory (USD) | 329.30M | 301.00M | 300.10M | 373.10M | 277.60M | 220.00M | 244.60M | 248.00M | 209.80M | 173.80M | 159.90M | 184.90M | 158.90M | 138.30M | 135.90M |
| Accounts Receivable (USD) | 342.30M | 341.70M | 359.80M | 334.60M | 284.50M | 221.40M | 292.00M | 279.70M | 244.50M | 154.40M | 137.40M | 164.30M | 135.80M | 115.70M | 99.40M |
| Current Assets (USD) | 1.00B | 956.60M | 885.70M | 872.60M | 728.10M | 566.20M | 630.30M | 663.90M | 561.50M | 441.10M | 458.70M | 414.20M | 407.40M | 296.60M | 320.30M |
| Assets (USD) | 1.83B | 1.73B | 1.71B | 1.60B | 1.57B | 1.40B | 1.47B | 1.47B | 1.41B | 1.18B | 1.03B | 999.90M | 794.70M | 579.40M | 568.80M |
News and Insights
The global specialty fuel additives market is projected to grow from $12.07 billion in 2025 to $22.40 billion by 2034, driven by stricter emission regulations, demand for cleaner fuels, and advancements in fuel additive technologies.
Innospec Inc. (NASDAQ: IOSP) announced that it will release its first quarter 2025 earnings results on May 8, 2025, and host a conference call on May 9, 2025 to discuss the results.
The global rocket hybrid propulsion market is expected to reach US$ 6.30 billion by 2033, growing at a CAGR of 6.50% during the forecast period. The market is driven by military advancements, growing space tourism, and innovative spacecraft applications, offering safety, efficiency, and environmental benefits.
The global Chlorinated Fatty Acid Methyl Ester (CFAME) market is projected to grow from $23.4 billion in 2023 to $39.7 billion by 2032, driven by the rising demand for eco-friendly chemicals. However, strict environmental regulations and competition from alternative additives pose challenges for CFAME's growth.
Innospec, a global specialty chemicals company, has partnered with UNESCO IESALC to launch an educational program aimed at improving access to STEM education for indigenous students in Brazil. The program will co-design a course on sustainable development and STEM, integrating indigenous knowledge and science.
The global chelating agent market is expected to grow significantly from 2025 to 2035, driven by increasing demand in water treatment, industrial cleaning, and agriculture. The shift towards biodegradable chelating agents is a key trend, with Asia-Pacific leading the market growth.
Innospec Inc. (NASDAQ: IOSP) announced that it will release its fourth quarter 2024 earnings results on February 18, 2025, and host a conference call on February 19, 2025. The company manufactures and supplies specialty chemicals for various industries.
Innospec reported its Q3 2024 financial results, with its Performance Chemicals and Fuel Specialties segments delivering double-digit operating income growth and margin expansion, while the Oilfield Services segment remained impacted by lower production chemical activity.
Innospec Inc. (NASDAQ: IOSP) announced that it will release its third quarter 2024 earnings results on November 5, 2024, and host a conference call on November 6, 2024 to discuss the results.